{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:01:53Z","timestamp":1780128113839,"version":"3.54.0"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"DOI":"10.1007\/s12602-026-11071-1","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:29:57Z","timestamp":1780126197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lactobacillaceae in Acute and Chronic Liver Diseases: From Microbiota Modulation to Therapeutic Potential"],"prefix":"10.1007","author":[{"given":"Xulan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"11071_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP et al (2023) Global burden of liver disease: 2023 update. J Hepatol 79:516\u2013537. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017","journal-title":"J Hepatol"},{"key":"11071_CR2","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG et al (2021) Liver cirrhosis. Lancet 398:1359\u20131376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X","journal-title":"Lancet"},{"key":"11071_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0140-6736(24)00693-7","volume":"404","author":"R Maiwall","year":"2024","unstructured":"Maiwall R, Kulkarni AV, Arab JP, Piano S (2024) Acute liver failure. Lancet 404:789\u2013802. https:\/\/doi.org\/10.1016\/S0140-6736(24)00693-7","journal-title":"Lancet"},{"key":"11071_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/alcalc\/agac013","volume":"57","author":"V Meza","year":"2022","unstructured":"Meza V, Arnold J, D\u00edaz LA et al (2022) Alcohol consumption: medical implications, the liver and beyond. Alcohol Alcohol 57:283\u2013291. https:\/\/doi.org\/10.1093\/alcalc\/agac013","journal-title":"Alcohol Alcohol"},{"key":"11071_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","volume":"1","author":"C Fitzmaurice","year":"2015","unstructured":"Fitzmaurice C, Dicker D, Pain A et al (2015) The global burden of cancer 2013. JAMA Oncol 1:505. https:\/\/doi.org\/10.1001\/jamaoncol.2015.0735","journal-title":"JAMA Oncol"},{"issue":"4","key":"11071_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-337431","volume":"75","author":"X-D Zhou","year":"2025","unstructured":"Zhou X-D, Fan Q-Y, Byrne CD et al (2025) Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities. Gut gutjnl-2025-337431. https:\/\/doi.org\/10.1136\/gutjnl-2025-337431","journal-title":"Gut"},{"key":"11071_CR7","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg H, Adolph TE, Trauner M (2022) Gut-liver axis: Pathophysiological concepts and clinical implications. Cell Metabol 34:1700\u20131718. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.017","journal-title":"Cell Metabol"},{"key":"11071_CR8","doi-asserted-by":"publisher","first-page":"10787","DOI":"10.1021\/acs.jafc.3c02617","volume":"71","author":"L Ye","year":"2023","unstructured":"Ye L, Chen H, Tsim KWK et al (2023) Aflatoxin B1 induces inflammatory liver injury via gut microbiota in mice. J Agric Food Chem 71:10787\u201310797. https:\/\/doi.org\/10.1021\/acs.jafc.3c02617","journal-title":"J Agric Food Chem"},{"issue":"1","key":"11071_CR9","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","volume":"7","author":"D Zhou","year":"2017","unstructured":"Zhou D, Pan Q, Shen F et al (2017) Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. Sci Rep 7:1529. https:\/\/doi.org\/10.1038\/s41598-017-01751-y","journal-title":"Sci Rep"},{"key":"11071_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04353-y","volume":"23","author":"G Lu","year":"2025","unstructured":"Lu G, Zhang S, Wang R et al (2025) Fecal microbiota transplantation improves bile acid malabsorption in patients with inflammatory bowel disease: results of microbiota and metabolites from two cohort studies. BMC Med 23:511. https:\/\/doi.org\/10.1186\/s12916-025-04353-y","journal-title":"BMC Med"},{"key":"11071_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2024-100099","volume":"2","author":"Z-N Ye","year":"2024","unstructured":"Ye Z-N, Eslick GD, Huang S-G, He X-X (2024) Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical postulation. eGastro 2:e100099. https:\/\/doi.org\/10.1136\/egastro-2024-100099","journal-title":"eGastro"},{"key":"11071_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120513","volume":"354","author":"Z Wang","year":"2026","unstructured":"Wang Z, Ren X, Peng Z et al (2026) Flavonoid-rich extracts of Nelumbo nucifera leaves alleviate obesity in HFD-fed mice via microbiota-dependent modulation of brown fat thermogenesis. J Ethnopharmacol 354:120513. https:\/\/doi.org\/10.1016\/j.jep.2025.120513","journal-title":"J Ethnopharmacol"},{"key":"11071_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G et al (2014) The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506\u2013514. https:\/\/doi.org\/10.1038\/nrgastro.2014.66","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11071_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1158\/0008-5472.CAN-22-3705","volume":"84","author":"Q Cao","year":"2024","unstructured":"Cao Q, Zhao M, Su Y et al (2024) Chronic stress dampens Lactobacillus johnsonii-mediated tumor suppression to enhance colorectal cancer progression. Cancer Res 84:771\u2013784. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3705","journal-title":"Cancer Res"},{"key":"11071_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2145843","volume":"14","author":"D-J-C Jia","year":"2022","unstructured":"Jia D-J-C, Wang Q-W, Hu Y-Y et al (2022) Lactobacillus johnsonii alleviates colitis by TLR1\/2-STAT3 mediated CD206\u2009+\u2009macrophagesIL-10 activation. Gut Microbes 14:2145843. https:\/\/doi.org\/10.1080\/19490976.2022.2145843","journal-title":"Gut Microbes"},{"key":"11071_CR16","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.apsb.2022.10.016","volume":"13","author":"X Fan","year":"2023","unstructured":"Fan X, Mai C, Zuo L et al (2023) Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice. Acta Pharm Sin B 13:1164\u20131179. https:\/\/doi.org\/10.1016\/j.apsb.2022.10.016","journal-title":"Acta Pharm Sin B"},{"key":"11071_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12602-021-09859-4","volume":"15","author":"H Yoon","year":"2023","unstructured":"Yoon H, Lee Y, Park H et al (2023) Lactobacillus johnsonii BFE6154 ameliorates diet-induced hypercholesterolemia. Probiotics Antimicro Prot 15:451\u2013459. https:\/\/doi.org\/10.1007\/s12602-021-09859-4","journal-title":"Probiotics Antimicro Prot"},{"key":"11071_CR18","doi-asserted-by":"publisher","first-page":"2405781","DOI":"10.1002\/advs.202405781","volume":"12","author":"R Yin","year":"2025","unstructured":"Yin R, Wang T, Sun J et al (2025) Postbiotics from lactobacillus johnsoniiactivates gut innate immunity to mitigate alcohol-associated liver disease. Adv Sci 12:2405781. https:\/\/doi.org\/10.1002\/advs.202405781","journal-title":"Adv Sci"},{"key":"11071_CR19","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1039\/d4fo01049c","volume":"15","author":"W Ma","year":"2024","unstructured":"Ma W, Lin X, Zhao Y et al (2024) Protective effect of Lactiplantibacillus plantarum CCFM8661 against heavy metal mixture-induced liver and kidney injury in mice. Food Funct 15:6565\u20136577. https:\/\/doi.org\/10.1039\/d4fo01049c","journal-title":"Food Funct"},{"key":"11071_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/hep.510250325","volume":"25","author":"D Adawi","year":"1997","unstructured":"Adawi D, Kasravi FB, Molin G, Jeppsson B (1997) Effect of lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology 25:642\u2013647. https:\/\/doi.org\/10.1002\/hep.510250325","journal-title":"Hepatology"},{"key":"11071_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2022.134643","volume":"404","author":"Z Lin","year":"2023","unstructured":"Lin Z, Wu J, Wang J et al (2023) Dietary Lactobacillusreuteri prevent from inflammation mediated apoptosis of liver via improving intestinal microbiota and bile acid metabolism. Food Chem 404:134643. https:\/\/doi.org\/10.1016\/j.foodchem.2022.134643","journal-title":"Food Chem"},{"key":"11071_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1751-7915.13750","volume":"15","author":"R Yan","year":"2022","unstructured":"Yan R, Wang K, Wang Q et al (2022) Probiotic Lactobacillus casei Shirota prevents acute liver injury by reshaping the gut microbiota to alleviate excessive inflammation and metabolic disorders. Microb Biotechnol 15:247\u2013261. https:\/\/doi.org\/10.1111\/1751-7915.13750","journal-title":"Microb Biotechnol"},{"key":"11071_CR23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chom.2023.04.002","volume":"31","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Wu R, Wang F et al (2023) Liberation of daidzein by gut microbial \u03b2-galactosidase suppresses acetaminophen-induced hepatotoxicity in mice. Cell Host Microbe 31:766-780.e7. https:\/\/doi.org\/10.1016\/j.chom.2023.04.002","journal-title":"Cell Host Microbe"},{"key":"11071_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200986","volume":"9","author":"Q-W Chen","year":"2022","unstructured":"Chen Q-W, Li Q-R, Cao M-W et al (2022) Hierarchy-assembled dual probiotics system ameliorates cholestatic drug-induced liver injury via gut-liver axis modulation. Advanced Science 9:e2200986. https:\/\/doi.org\/10.1002\/advs.202200986","journal-title":"Advanced Science"},{"key":"11071_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107275","volume":"206","author":"S Hu","year":"2024","unstructured":"Hu S, Tang B, Lu C et al (2024) Lactobacillus rhamnosus GG ameliorates triptolide-induced liver injury through modulation of the bile acid-FXR axis. Pharmacol Res 206:107275. https:\/\/doi.org\/10.1016\/j.phrs.2024.107275","journal-title":"Pharmacol Res"},{"key":"11071_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713424","volume":"24","author":"T You","year":"2023","unstructured":"You T, Zhao Y, Liu S, Xu H (2023) Lactiplantibacillus plantarum P101 attenuated cyclophosphamide-induced liver injury in mice by regulating the Nrf2\/ARE signaling pathway. Int J Mol Sci 24:13424. https:\/\/doi.org\/10.3390\/ijms241713424","journal-title":"Int J Mol Sci"},{"key":"11071_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119444","volume":"24","author":"Y Li","year":"2023","unstructured":"Li Y, Zhao L, Sun C et al (2023) Regulation of gut microflora by Lactobacillus casei Zhang attenuates liver injury in mice caused by anti-tuberculosis drugs. Int J Mol Sci 24:9444. https:\/\/doi.org\/10.3390\/ijms24119444","journal-title":"Int J Mol Sci"},{"key":"11071_CR28","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/hep.30975","volume":"71","author":"Y Liu","year":"2020","unstructured":"Liu Y, Chen K, Li F et al (2020) Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice. Hepatology 71:2050\u20132066. https:\/\/doi.org\/10.1002\/hep.30975","journal-title":"Hepatology"},{"key":"11071_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2390176","volume":"16","author":"L Wu","year":"2024","unstructured":"Wu L, Zhou J, Zhou A et al (2024) Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion. Gut Microbes 16:2390176. https:\/\/doi.org\/10.1080\/19490976.2024.2390176","journal-title":"Gut Microbes"},{"key":"11071_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1840766","volume":"12","author":"AA Santos","year":"2020","unstructured":"Santos AA, Afonso MB, Ramiro RS et al (2020) Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice. Gut Microbes 12:1\u201318. https:\/\/doi.org\/10.1080\/19490976.2020.1840766","journal-title":"Gut Microbes"},{"key":"11071_CR31","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.jnutbio.2013.02.001","volume":"24","author":"Y Wang","year":"2013","unstructured":"Wang Y, Liu Y, Kirpich I et al (2013) Lactobacillus rhamnosus GG reduces hepatic TNF\u03b1 production and inflammation in chronic alcohol-induced liver injury. J Nutr Biochem 24:1609\u20131615. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.02.001","journal-title":"J Nutr Biochem"},{"key":"11071_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2022.111259","volume":"157","author":"Q Ding","year":"2022","unstructured":"Ding Q, Cao F, Lai S et al (2022) Lactobacillus plantarum ZY08 relieves chronic alcohol-induced hepatic steatosis and liver injury in mice via restoring intestinal flora homeostasis. Food Res Int 157:111259. https:\/\/doi.org\/10.1016\/j.foodres.2022.111259","journal-title":"Food Res Int"},{"key":"11071_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-023-00974-z","volume":"13","author":"L Chen","year":"2023","unstructured":"Chen L, Yang P, Hu L et al (2023) Modulating phenylalanine metabolism by L. acidophilus alleviates alcohol-related liver disease through enhancing intestinal barrier function. Cell Biosci 13:24. https:\/\/doi.org\/10.1186\/s13578-023-00974-z","journal-title":"Cell Biosci"},{"key":"11071_CR34","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1039\/c8fo00252e","volume":"9","author":"W-G Kim","year":"2018","unstructured":"Kim W-G, Kim HI, Kwon EK et al (2018) Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-\u03baB activation through restoration of the disturbed gut microbiota. Food Funct 9:4255\u20134265. https:\/\/doi.org\/10.1039\/c8fo00252e","journal-title":"Food Funct"},{"key":"11071_CR35","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1039\/d4fo02592j","volume":"15","author":"B Niu","year":"2024","unstructured":"Niu B, Feng Y, Cheng X et al (2024) The alleviative effects of viable and inactive Lactobacillus paracasei CCFM1120 against alcoholic liver disease via modulation of gut microbiota and the Nrf2\/HO-1 and TLR4\/MyD88\/NF-\u03baB pathways. Food Funct 15:8797\u20138809. https:\/\/doi.org\/10.1039\/d4fo02592j","journal-title":"Food Funct"},{"key":"11071_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1021\/acs.jafc.0c06346","volume":"69","author":"H Li","year":"2021","unstructured":"Li H, Shi J, Zhao L et al (2021) Lactobacillus plantarum KLDS1.0344 and Lactobacillus acidophilus KLDS1.0901 mixture prevents chronic alcoholic liver injury in mice by protecting the intestinal barrier and regulating gut microbiota and liver-related pathways. J Agric Food Chem 69:183\u2013197. https:\/\/doi.org\/10.1021\/acs.jafc.0c06346","journal-title":"J Agric Food Chem"},{"key":"11071_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.70016","volume":"17","author":"J Lv","year":"2024","unstructured":"Lv J, Lang G, Wang Q et al (2024) Lactobacillus helveticus attenuates alcoholic liver injury via regulation of gut microecology in mice. Microb Biotechnol 17:e70016. https:\/\/doi.org\/10.1111\/1751-7915.70016","journal-title":"Microb Biotechnol"},{"key":"11071_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.634","volume":"11","author":"JS Yu","year":"2021","unstructured":"Yu JS, Youn GS, Choi J et al (2021) Lactobacilluslactis and Pediococcuspentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease. Clin Transl Med 11:e634. https:\/\/doi.org\/10.1002\/ctm2.634","journal-title":"Clin Transl Med"},{"key":"11071_CR39","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1039\/c9fo02905b","volume":"11","author":"G Wang","year":"2020","unstructured":"Wang G, Jiao T, Xu Y et al (2020) Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways. Food Funct 11:6115\u20136127. https:\/\/doi.org\/10.1039\/c9fo02905b","journal-title":"Food Funct"},{"key":"11071_CR40","doi-asserted-by":"publisher","first-page":"8707","DOI":"10.1039\/d0fo01823f","volume":"11","author":"J Mu","year":"2020","unstructured":"Mu J, Tan F, Zhou X, Zhao X (2020) Lactobacillus fermentum CQPC06 in naturally fermented pickles prevents non-alcoholic fatty liver disease by stabilizing the gut-liver axis in mice. Food Funct 11:8707\u20138723. https:\/\/doi.org\/10.1039\/d0fo01823f","journal-title":"Food Funct"},{"key":"11071_CR41","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1039\/c9fo03003d","volume":"11","author":"M Chen","year":"2020","unstructured":"Chen M, Guo W-L, Li Q-Y et al (2020) The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet. Food Funct 11:3316\u20133331. https:\/\/doi.org\/10.1039\/c9fo03003d","journal-title":"Food Funct"},{"key":"11071_CR42","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1038\/s12276-023-01102-0","volume":"55","author":"DY Kim","year":"2023","unstructured":"Kim DY, Park JY, Gee HY (2023) Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating L-arginine production. Exp Mol Med 55:2332\u20132345. https:\/\/doi.org\/10.1038\/s12276-023-01102-0","journal-title":"Exp Mol Med"},{"key":"11071_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/nu16070958","volume":"16","author":"Q Teng","year":"2024","unstructured":"Teng Q, Lv H, Peng L et al (2024) Lactiplantibacillus plantarum ZDY2013 inhibits the development of non-alcoholic fatty liver disease by regulating the intestinal microbiota and modulating the PI3K\/Akt pathway. Nutrients 16:958. https:\/\/doi.org\/10.3390\/nu16070958","journal-title":"Nutrients"},{"key":"11071_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10112203","volume":"10","author":"P Werlinger","year":"2022","unstructured":"Werlinger P, Nguyen HT, Gu M et al (2022) Lactobacillus reuteri MJM60668 prevent progression of non-alcoholic fatty liver disease through anti-adipogenesis and anti-inflammatory pathway. Microorganisms 10:2203. https:\/\/doi.org\/10.3390\/microorganisms10112203","journal-title":"Microorganisms"},{"key":"11071_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42312-w","volume":"13","author":"K He","year":"2023","unstructured":"He K, Liu M, Wang Q et al (2023) Combined analysis of 16S rDNA sequencing and metabolomics to find biomarkers of drug-induced liver injury. Sci Rep 13:15138. https:\/\/doi.org\/10.1038\/s41598-023-42312-w","journal-title":"Sci Rep"},{"key":"11071_CR46","doi-asserted-by":"publisher","first-page":"772368","DOI":"10.3389\/fimmu.2022.772368","volume":"13","author":"S Zhao","year":"2022","unstructured":"Zhao S, Fu H, Zhou T et al (2022) Alteration of bile acids and omega-6 PUFAs are correlated with the progression and prognosis of drug-induced liver injury. Front Immunol 13:772368. https:\/\/doi.org\/10.3389\/fimmu.2022.772368","journal-title":"Front Immunol"},{"key":"11071_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.intimp.2012.10.026","volume":"15","author":"Y Wang","year":"2013","unstructured":"Wang Y, Li Y, Xie J et al (2013) Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. Int Immunopharmacol 15:30\u201337. https:\/\/doi.org\/10.1016\/j.intimp.2012.10.026","journal-title":"Int Immunopharmacol"},{"key":"11071_CR48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00394-015-0904-3","volume":"55","author":"Y Wang","year":"2016","unstructured":"Wang Y, Xie J, Li Y et al (2016) Probiotic lactobacillus casei zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure. Eur J Nutr 55:821\u2013831. https:\/\/doi.org\/10.1007\/s00394-015-0904-3","journal-title":"Eur J Nutr"},{"key":"11071_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0168-1605(01)00550-5","volume":"70","author":"D Adawi","year":"2001","unstructured":"Adawi D, Ahrn\u00e9 S, Molin G (2001) Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model. Int J Food Microbiol 70:213\u2013220. https:\/\/doi.org\/10.1016\/s0168-1605(01)00550-5","journal-title":"Int J Food Microbiol"},{"key":"11071_CR50","doi-asserted-by":"publisher","first-page":"e0038421","DOI":"10.1128\/mSystems.00384-21","volume":"6","author":"L Lv","year":"2021","unstructured":"Lv L, Yao C, Yan R et al (2021) Lactobacillus acidophilus LA14 Alleviates Liver Injury. mSystems 6:e0038421. https:\/\/doi.org\/10.1128\/mSystems.00384-21","journal-title":"mSystems"},{"key":"11071_CR51","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1111\/1751-7915.13629","volume":"13","author":"L Yang","year":"2020","unstructured":"Yang L, Bian X, Wu W et al (2020) Protective effect of Lactobacillus salivarius Li01 on thioacetamide-induced acute liver injury and hyperammonaemia. Microb Biotechnol 13:1860\u20131876. https:\/\/doi.org\/10.1111\/1751-7915.13629","journal-title":"Microb Biotechnol"},{"key":"11071_CR52","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1007\/s00253-014-5638-2","volume":"98","author":"L-X Lv","year":"2014","unstructured":"Lv L-X, Hu X-J, Qian G-R et al (2014) Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by D-galactosamine in rats. Appl Microbiol Biotechnol 98:5619\u20135632. https:\/\/doi.org\/10.1007\/s00253-014-5638-2","journal-title":"Appl Microbiol Biotechnol"},{"key":"11071_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01847-21","volume":"9","author":"P Lou","year":"2021","unstructured":"Lou P, Shen Y, Zhuge A et al (2021) Dose-dependent relationship between protection of thioacetamide-induced acute liver injury and hyperammonemia and concentration of Lactobacillus salivarius Li01 in mice. Microbiol Spectr 9:e0184721. https:\/\/doi.org\/10.1128\/spectrum.01847-21","journal-title":"Microbiol Spectr"},{"key":"11071_CR54","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s10753-014-9886-1","volume":"37","author":"X Peng","year":"2014","unstructured":"Peng X, Jiang Y (2014) Protective effects of Lactobacillus plantarum NDC 75017 against lipopolysaccharide-induced liver injury in mice. Inflammation 37:1599\u20131607. https:\/\/doi.org\/10.1007\/s10753-014-9886-1","journal-title":"Inflammation"},{"key":"11071_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/DDDT.S286104","volume":"15","author":"C Li","year":"2021","unstructured":"Li C, Si J, Tan F et al (2021) Lactobacillus plantarum KSFY06 prevents inflammatory response and oxidative stress in acute liver injury induced by D-Gal\/LPS in mice. Drug Des Devel Ther 15:37\u201350. https:\/\/doi.org\/10.2147\/DDDT.S286104","journal-title":"Drug Des Devel Ther"},{"key":"11071_CR56","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1111\/1750-3841.16171","volume":"87","author":"X Long","year":"2022","unstructured":"Long X, Wang P, Zhou Y et al (2022) Preventive effect of Lactobacillus plantarum HFY15 on carbon tetrachloride (CCl4 )-induced acute liver injury in mice. J Food Sci 87:2626\u20132639. https:\/\/doi.org\/10.1111\/1750-3841.16171","journal-title":"J Food Sci"},{"key":"11071_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113433","volume":"169","author":"N Zhang","year":"2022","unstructured":"Zhang N, Tian Y, Wang Y et al (2022) Ameliorative effect of Lactobacillus plantarum Lp2 against cyclophosphamide-induced liver injury in mice. Food Chem Toxicol 169:113433. https:\/\/doi.org\/10.1016\/j.fct.2022.113433","journal-title":"Food Chem Toxicol"},{"key":"11071_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/s0168-8278(97)80060-8","volume":"26","author":"FB Kasravi","year":"1997","unstructured":"Kasravi FB, Adawi D, Molin G et al (1997) Effect of oral supplementation of lactobacilli on bacterial translocation in acute liver injury induced by D-galactosamine. J Hepatol 26:417\u2013424. https:\/\/doi.org\/10.1016\/s0168-8278(97)80060-8","journal-title":"J Hepatol"},{"key":"11071_CR59","doi-asserted-by":"publisher","first-page":"9673","DOI":"10.1007\/s00253-019-10211-8","volume":"103","author":"Q Wang","year":"2019","unstructured":"Wang Q, Lv L, Jiang H et al (2019) Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats. Appl Microbiol Biotechnol 103:9673\u20139686. https:\/\/doi.org\/10.1007\/s00253-019-10211-8","journal-title":"Appl Microbiol Biotechnol"},{"key":"11071_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111000","volume":"133","author":"H Jiang","year":"2021","unstructured":"Jiang H, Yan R, Wang K et al (2021) Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats. Biomed Pharmacother 133:111000. https:\/\/doi.org\/10.1016\/j.biopha.2020.111000","journal-title":"Biomed Pharmacother"},{"key":"11071_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082212","volume":"19","author":"X Chen","year":"2018","unstructured":"Chen X, Zhang J, Yi R et al (2018) Hepatoprotective effects of Lactobacillus on Carbon Tetrachloride-induced acute liver injury in mice. Int J Mol Sci 19:2212. https:\/\/doi.org\/10.3390\/ijms19082212","journal-title":"Int J Mol Sci"},{"key":"11071_CR62","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1093\/jn\/nxz088","volume":"149","author":"Y Cui","year":"2019","unstructured":"Cui Y, Qi S, Zhang W et al (2019) Lactobacillus reuteri ZJ617 culture supernatant attenuates acute liver injury induced in mice by Lipopolysaccharide. J Nutr 149:2046\u20132055. https:\/\/doi.org\/10.1093\/jn\/nxz088","journal-title":"J Nutr"},{"key":"11071_CR63","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2607229","volume":"58","author":"R Song","year":"2026","unstructured":"Song R, Li M, Tang S, Zhang G (2026) Immunotherapy for virus-related hepatocellular carcinoma: recent progress and future directions. Ann Med 58:2607229. https:\/\/doi.org\/10.1080\/07853890.2025.2607229","journal-title":"Ann Med"},{"key":"11071_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00377","volume":"9","author":"Q Zhu","year":"2019","unstructured":"Zhu Q, Xia P, Zhou X et al (2019) Hepatitis B Virus infection alters gut microbiota composition in mice. Front Cell Infect Microbiol 9:377. https:\/\/doi.org\/10.3389\/fcimb.2019.00377","journal-title":"Front Cell Infect Microbiol"},{"key":"11071_CR65","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jmv.27356","volume":"94","author":"J Wu","year":"2022","unstructured":"Wu J, Bortolanza M, Zhai G et al (2022) Gut microbiota dysbiosis associated with plasma levels of Interferon-\u03b3 and viral load in patients with acute hepatitis E infection. J Med Virol 94:692\u2013702. https:\/\/doi.org\/10.1002\/jmv.27356","journal-title":"J Med Virol"},{"key":"11071_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1921925","volume":"13","author":"K Wang","year":"2021","unstructured":"Wang K, Zhang Z, Mo Z-S et al (2021) Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure. Gut Microbes 13:1\u201315. https:\/\/doi.org\/10.1080\/19490976.2021.1921925","journal-title":"Gut Microbes"},{"key":"11071_CR67","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","volume":"76","author":"P Luukkonen","year":"2022","unstructured":"Luukkonen P, Qadri S, Ahlholm N et al (2022) Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. J Hepatol 76:526\u2013535. https:\/\/doi.org\/10.1016\/j.jhep.2021.10.013","journal-title":"J Hepatol"},{"key":"11071_CR68","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/srep08096","volume":"5","author":"W Jiang","year":"2015","unstructured":"Jiang W, Wu N, Wang X et al (2015) Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep 5:8096. https:\/\/doi.org\/10.1038\/srep08096","journal-title":"Sci Rep"},{"key":"11071_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37163-4","volume":"13","author":"C Yang","year":"2023","unstructured":"Yang C, Xu J, Xu X et al (2023) Characteristics of gut microbiota in patients with metabolic associated fatty liver disease. Sci Rep 13:9988. https:\/\/doi.org\/10.1038\/s41598-023-37163-4","journal-title":"Sci Rep"},{"key":"11071_CR70","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3945\/jn.112.172460","volume":"143","author":"H Zeng","year":"2013","unstructured":"Zeng H, Liu J, Jackson MI et al (2013) Fatty liver accompanies an increase in lactobacillus species in the hind gut of C57BL\/6 mice fed a high-fat diet. J Nutr 143:627\u2013631. https:\/\/doi.org\/10.3945\/jn.112.172460","journal-title":"J Nutr"},{"key":"11071_CR71","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1053\/j.gastro.2020.03.010","volume":"159","author":"CR Naudin","year":"2020","unstructured":"Naudin CR, Maner-Smith K, Owens JA et al (2020) Lactococcus lactis subspecies cremoris elicits protection against metabolic changes induced by a western-style diet. Gastroenterology 159:639\u2013651e5. https:\/\/doi.org\/10.1053\/j.gastro.2020.03.010","journal-title":"Gastroenterology"},{"key":"11071_CR72","doi-asserted-by":"publisher","first-page":"6817","DOI":"10.1007\/s00253-014-5752-1","volume":"98","author":"J Xin","year":"2014","unstructured":"Xin J, Zeng D, Wang H et al (2014) Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. Appl Microbiol Biotechnol 98:6817\u20136829. https:\/\/doi.org\/10.1007\/s00253-014-5752-1","journal-title":"Appl Microbiol Biotechnol"},{"key":"11071_CR73","doi-asserted-by":"publisher","first-page":"1146672","DOI":"10.3389\/fmicb.2023.1146672","volume":"14","author":"X Wen","year":"2023","unstructured":"Wen X, Liu H, Luo X et al (2023) Supplementation of Lactobacillus plantarum ATCC14917 mitigates non-alcoholic fatty liver disease in high-fat-diet-fed rats. Front Microbiol 14:1146672. https:\/\/doi.org\/10.3389\/fmicb.2023.1146672","journal-title":"Front Microbiol"},{"key":"11071_CR74","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/metabo13101043","volume":"13","author":"J Xu","year":"2023","unstructured":"Xu J, Zhou Y, Cheng S et al (2023) Lactobacillus johnsonii attenuates liver steatosis and bile acid dysregulation in parenteral nutrition-fed rats. Metabolites 13:1043. https:\/\/doi.org\/10.3390\/metabo13101043","journal-title":"Metabolites"},{"key":"11071_CR75","doi-asserted-by":"publisher","unstructured":"Choi S-I, You S, Kim S et al (2021) Weissella cibaria MG5285 and Lactobacillus reuteri MG5149 attenuated fat accumulation in adipose and hepatic steatosis in high-fat diet-induced C57BL\/6J obese mice. Food Nutr Res 65. https:\/\/doi.org\/10.29219\/fnr.v65.8087","DOI":"10.29219\/fnr.v65.8087"},{"key":"11071_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1147423","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang Z, Wan Y et al (2023) Assessing the in vivo ameliorative effects of Lactobacillus acidophilus KLDS1.0901 for induced non-alcoholic fatty liver disease treatment. Front Nutr 10:1147423. https:\/\/doi.org\/10.3389\/fnut.2023.1147423","journal-title":"Front Nutr"},{"key":"11071_CR77","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3350\/cmh.2020.0125","volume":"27","author":"NY Lee","year":"2021","unstructured":"Lee NY, Shin MJ, Youn GS et al (2021) Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis. Clin Mol Hepatol 27:110\u2013124. https:\/\/doi.org\/10.3350\/cmh.2020.0125","journal-title":"Clin Mol Hepatol"},{"key":"11071_CR78","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1021\/acs.jproteome.8b00282","volume":"17","author":"A Martinic","year":"2018","unstructured":"Martinic A, Barouei J, Bendiks Z et al (2018) Supplementation of lactobacillus plantarum improves markers of metabolic dysfunction induced by a high fat diet. J Proteome Res 17:2790\u20132802. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00282","journal-title":"J Proteome Res"},{"key":"11071_CR79","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3390\/foods9101494","volume":"9","author":"G Yang","year":"2020","unstructured":"Yang G, Hong E, Oh S, Kim E (2020) Non-viable lactobacillus johnsonii JNU3402 protects against diet-induced obesity. Foods 9:1494. https:\/\/doi.org\/10.3390\/foods9101494","journal-title":"Foods"},{"key":"11071_CR80","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/apt.15754","volume":"51","author":"T Liwinski","year":"2020","unstructured":"Liwinski T, Casar C, Ruehlemann MC et al (2020) A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis. Aliment Pharmacol Ther 51:1417\u20131428. https:\/\/doi.org\/10.1111\/apt.15754","journal-title":"Aliment Pharmacol Ther"},{"key":"11071_CR81","doi-asserted-by":"publisher","first-page":"1197847","DOI":"10.3389\/fphar.2023.1197847","volume":"14","author":"S Wei","year":"2023","unstructured":"Wei S, He T, Zhao X et al (2023) Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice. Front Pharmacol 14:1197847. https:\/\/doi.org\/10.3389\/fphar.2023.1197847","journal-title":"Front Pharmacol"},{"key":"11071_CR82","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00127-24","volume":"9","author":"X Yang","year":"2024","unstructured":"Yang X, Xu Y, Li J et al (2024) Bile acid-gut microbiota imbalance in cholestasis and its long-term effect in mice. mSystems 9:e0012724. https:\/\/doi.org\/10.1128\/msystems.00127-24","journal-title":"mSystems"},{"key":"11071_CR83","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1136\/gutjnl-2018-316670","volume":"68","author":"L Liao","year":"2019","unstructured":"Liao L, Schneider KM, Galvez EJC et al (2019) Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis. Gut 68:1477\u20131492. https:\/\/doi.org\/10.1136\/gutjnl-2018-316670","journal-title":"Gut"},{"key":"11071_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311010","volume":"24","author":"Y Shen","year":"2023","unstructured":"Shen Y, Jiang B, Zhang C et al (2023) Combined inhibition of the TGF-\u03b21\/Smad pathway by Prevotella copri and Lactobacillus murinus to reduce inflammation and fibrosis in primary sclerosing cholangitis. IJMS 24:11010. https:\/\/doi.org\/10.3390\/ijms241311010","journal-title":"IJMS"},{"key":"11071_CR85","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00383-014-3643-2","volume":"31","author":"F Sarac","year":"2015","unstructured":"Sarac F, Salman T, Gun F et al (2015) Effect of probiotic supplementation on bacterial translocation in common bile duct obstruction. Pediatr Surg Int 31:155\u2013161. https:\/\/doi.org\/10.1007\/s00383-014-3643-2","journal-title":"Pediatr Surg Int"},{"key":"11071_CR86","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/hep.30975","volume":"71","author":"Y Liu","year":"2020","unstructured":"Liu Y, Chen K, Li F et al (2020) Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice. Hepatology 71:2050\u20132066. https:\/\/doi.org\/10.1002\/hep.30975","journal-title":"Hepatology"},{"key":"11071_CR87","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12602-022-10033-7","volume":"16","author":"S Kabiri-Arani","year":"2024","unstructured":"Kabiri-Arani S, Motallebi M, Taheri MA et al (2024) The effect of heat-killed Lactobacillus plantarum on oxidative stress and liver damage in rats with bile duct ligation-induced hepatic fibrosis. Probiotics Antimicrob Proteins 16:196\u2013211. https:\/\/doi.org\/10.1007\/s12602-022-10033-7","journal-title":"Probiotics Antimicrob Proteins"},{"key":"11071_CR88","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2390176","volume":"16","author":"L Wu","year":"2024","unstructured":"Wu L, Zhou J, Zhou A et al (2024) Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion. Gut Microbes 16:2390176. https:\/\/doi.org\/10.1080\/19490976.2024.2390176","journal-title":"Gut Microbes"},{"key":"11071_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0359-2","volume":"5","author":"VB Dubinkina","year":"2017","unstructured":"Dubinkina VB, Tyakht AV, Odintsova VY et al (2017) Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome 5:141. https:\/\/doi.org\/10.1186\/s40168-017-0359-2","journal-title":"Microbiome"},{"key":"11071_CR90","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2281014","volume":"15","author":"JA Eom","year":"2023","unstructured":"Eom JA, Jeong J-J, Han SH et al (2023) Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease. Gut Microbes 15:2281014. https:\/\/doi.org\/10.1080\/19490976.2023.2281014","journal-title":"Gut Microbes"},{"key":"11071_CR91","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201800351R","volume":"32","author":"PK Shukla","year":"2018","unstructured":"Shukla PK, Meena AS, Manda B et al (2018) Lactobacillus plantarum prevents and mitigates alcohol-induced disruption of colonic epithelial tight junctions, endotoxemia, and liver damage by an EGF receptor-dependent mechanism. FASEB J 32:fj201800351R. https:\/\/doi.org\/10.1096\/fj.201800351R","journal-title":"FASEB J"},{"key":"11071_CR92","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7337988","volume":"2021","author":"Y Gan","year":"2021","unstructured":"Gan Y, Chen X, Yi R, Zhao X (2021) Antioxidative and anti-inflammatory effects of Lactobacillus plantarum ZS62 on alcohol-induced subacute hepatic damage. Oxid Med Cell Longev 2021:7337988. https:\/\/doi.org\/10.1155\/2021\/7337988","journal-title":"Oxid Med Cell Longev"},{"key":"11071_CR93","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijfoodmicro.2008.09.023","volume":"128","author":"S Segawa","year":"2008","unstructured":"Segawa S, Wakita Y, Hirata H, Watari J (2008) Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL\/6N mice. Int J Food Microbiol 128:371\u2013377. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2008.09.023","journal-title":"Int J Food Microbiol"},{"key":"11071_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051896","volume":"21","author":"M Noda","year":"2020","unstructured":"Noda M, Maruyama M, Danshiitsoodol N et al (2020) Improvement of alcohol-poisoning symptoms in mice by the oral administration of live Lactobacillus plantarum SN13T cells. Int J Mol Sci 21:1896. https:\/\/doi.org\/10.3390\/ijms21051896","journal-title":"Int J Mol Sci"},{"key":"11071_CR95","doi-asserted-by":"publisher","first-page":"32","DOI":"10.17998\/jlc.20.1.32","volume":"20","author":"J Seok","year":"2020","unstructured":"Seok J, Suk KT (2020) Gut-microbiome taxonomic profiling as non-invasive biomarkers for the early detection of alcoholic hepatocellular carcinoma. J Liver Cancer 20:32\u201340. https:\/\/doi.org\/10.17998\/jlc.20.1.32","journal-title":"J Liver Cancer"},{"key":"11071_CR96","doi-asserted-by":"publisher","first-page":"e00131","DOI":"10.14309\/ctg.0000000000000131","volume":"11","author":"S Sydor","year":"2020","unstructured":"Sydor S, Best J, Messerschmidt I et al (2020) Altered microbiota diversity and bile acid signaling in cirrhotic and noncirrhotic NASH-HCC. Clin Transl Gastroenterol 11:e00131. https:\/\/doi.org\/10.14309\/ctg.0000000000000131","journal-title":"Clin Transl Gastroenterol"},{"key":"11071_CR97","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jhep.2012.06.011","volume":"57","author":"H-L Zhang","year":"2012","unstructured":"Zhang H-L, Yu L-X, Yang W et al (2012) Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J Hepatol 57:803\u2013812. https:\/\/doi.org\/10.1016\/j.jhep.2012.06.011","journal-title":"J Hepatol"},{"key":"11071_CR98","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.32449","volume":"77","author":"C Hu","year":"2023","unstructured":"Hu C, Xu B, Wang X et al (2023) Gut microbiota\u2013derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC. Hepatology 77:48\u201364. https:\/\/doi.org\/10.1002\/hep.32449","journal-title":"Hepatology"},{"key":"11071_CR99","doi-asserted-by":"publisher","first-page":"104952","DOI":"10.1016\/j.ebiom.2023.104952","volume":"100","author":"HC-H Lau","year":"2024","unstructured":"Lau HC-H, Zhang X, Ji F et al (2024) Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid. EBioMedicine 100:104952. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104952","journal-title":"EBioMedicine"},{"key":"11071_CR100","doi-asserted-by":"publisher","first-page":"1451170","DOI":"10.3389\/fmicb.2024.1451170","volume":"15","author":"OP Duduyemi","year":"2024","unstructured":"Duduyemi OP, Potapenko K, Limanska N et al (2024) Lactiplantibacillus plantarum inhibited the growth of primary liver cancer by inducing early apoptosis and senescence, in vitro. Front Microbiol 15:1451170. https:\/\/doi.org\/10.3389\/fmicb.2024.1451170","journal-title":"Front Microbiol"},{"key":"11071_CR101","doi-asserted-by":"publisher","first-page":"1179014","DOI":"10.3389\/fimmu.2023.1179014","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen S, Han P, Zhang Q et al (2023) Lactobacillus brevis alleviates the progress of hepatocellular carcinoma and type 2 diabetes in mice model via interplay of gut microflora, bile acid and NOTCH 1 signaling. Front Immunol 14:1179014. https:\/\/doi.org\/10.3389\/fimmu.2023.1179014","journal-title":"Front Immunol"},{"key":"11071_CR102","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/ajcn\/83.5.1199","volume":"83","author":"HS El-Nezami","year":"2006","unstructured":"El-Nezami HS, Polychronaki NN, Ma J et al (2006) Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am J Clin Nutr 83:1199\u20131203. https:\/\/doi.org\/10.1093\/ajcn\/83.5.1199","journal-title":"Am J Clin Nutr"},{"key":"11071_CR103","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B (2023) The gut\u2013liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol 21:719\u2013733. https:\/\/doi.org\/10.1038\/s41579-023-00904-3","journal-title":"Nat Rev Microbiol"},{"key":"11071_CR104","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mib.2018.06.003","volume":"44","author":"K Korpela","year":"2018","unstructured":"Korpela K, De Vos WM (2018) Early life colonization of the human gut: microbes matter everywhere. Curr Opin Microbiol 44:70\u201378. https:\/\/doi.org\/10.1016\/j.mib.2018.06.003","journal-title":"Curr Opin Microbiol"},{"key":"11071_CR105","doi-asserted-by":"publisher","first-page":"e80169","DOI":"10.1371\/journal.pone.0080169","volume":"9","author":"Y Ritze","year":"2014","unstructured":"Ritze Y, B\u00e1rdos G, Claus A et al (2014) Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS ONE 9:e80169. https:\/\/doi.org\/10.1371\/journal.pone.0080169","journal-title":"PLoS ONE"},{"key":"11071_CR106","doi-asserted-by":"publisher","first-page":"1071284","DOI":"10.3389\/fnut.2022.1071284","volume":"9","author":"F Cao","year":"2022","unstructured":"Cao F, Ding Q, Zhuge H et al (2022) Lactobacillus plantarum ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota. Front Nutr 9:1071284. https:\/\/doi.org\/10.3389\/fnut.2022.1071284","journal-title":"Front Nutr"},{"key":"11071_CR107","doi-asserted-by":"publisher","first-page":"G911","DOI":"10.1152\/ajpgi.00225.2013","volume":"305","author":"H Okubo","year":"2013","unstructured":"Okubo H, Sakoda H, Kushiyama A et al (2013) Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model. Am J Physiol Gastrointest Liver Physiol 305:G911\u2013918. https:\/\/doi.org\/10.1152\/ajpgi.00225.2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"11071_CR108","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1002\/jsfa.12774","volume":"103","author":"W Song","year":"2023","unstructured":"Song W, Wang T, Cui X et al (2023) Lactobacilluscoryniformissubsp.torquens T3 alleviates non-alcoholic fatty liver disease via reconstruction of the gut microbiota and redox system. J Sci Food Agric 103:6814\u20136825. https:\/\/doi.org\/10.1002\/jsfa.12774","journal-title":"J Sci Food Agric"},{"key":"11071_CR109","doi-asserted-by":"publisher","first-page":"14951","DOI":"10.1021\/acs.jafc.3c00278","volume":"71","author":"Z Wu","year":"2023","unstructured":"Wu Z, He J, Zhang Z et al (2023) Propionic acid driven by the Lactobacillusjohnsonii culture supernatant alleviates colitis by inhibiting M1 macrophage polarization by modulating the MAPK pathway in mice. J Agric Food Chem 71:14951\u201314966. https:\/\/doi.org\/10.1021\/acs.jafc.3c00278","journal-title":"J Agric Food Chem"},{"key":"11071_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106020","volume":"175","author":"Y Kang","year":"2022","unstructured":"Kang Y, Kang X, Yang H et al (2022) Lactobacillusacidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability. Pharmacol Res 175:106020. https:\/\/doi.org\/10.1016\/j.phrs.2021.106020","journal-title":"Pharmacol Res"},{"key":"11071_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2022.111259","volume":"157","author":"Q Ding","year":"2022","unstructured":"Ding Q, Cao F, Lai S et al (2022) Lactobacillusplantarum ZY08 relieves chronic alcohol-induced hepatic steatosis and liver injury in mice via restoring intestinal flora homeostasis. Food Res Int 157:111259. https:\/\/doi.org\/10.1016\/j.foodres.2022.111259","journal-title":"Food Res Int"},{"key":"11071_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41538-022-00167-x","volume":"6","author":"Y Li","year":"2022","unstructured":"Li Y, Chen M, Ma Y et al (2022) Regulation of viable\/inactivated\/lysed probiotic Lactobacillusplantarum H6 on intestinal microbiota and metabolites in hypercholesterolemic mice. NPJ Sci Food 6:50. https:\/\/doi.org\/10.1038\/s41538-022-00167-x","journal-title":"NPJ Sci Food"},{"key":"11071_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202200496","volume":"67","author":"E Hong","year":"2023","unstructured":"Hong E, Kang H, Yang G et al (2023) The PKA-SREBP1c pathway plays a key role in the protective effects of Lactobacillusjohnsonii JNU3402 against diet-induced fatty liver in mice. Mol Nutr Food Res 67:e2200496. https:\/\/doi.org\/10.1002\/mnfr.202200496","journal-title":"Mol Nutr Food Res"},{"key":"11071_CR114","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1128\/aem.62.5.1589-1592.1996","volume":"62","author":"TL Miller","year":"1996","unstructured":"Miller TL, Wolin MJ (1996) Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol 62:1589\u20131592. https:\/\/doi.org\/10.1128\/aem.62.5.1589-1592.1996","journal-title":"Appl Environ Microbiol"},{"key":"11071_CR115","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/jam.15135","volume":"132","author":"M Pe\u00f1a-Rodr\u00edguez","year":"2022","unstructured":"Pe\u00f1a-Rodr\u00edguez M, Vega-Maga\u00f1a N, Garc\u00eda-Benavides L et al (2022) Butyrate administration strengthens the intestinal epithelium and improves intestinal dysbiosis in a cholestasis fibrosis model. J Appl Microbiol 132:571\u2013583. https:\/\/doi.org\/10.1111\/jam.15135","journal-title":"J Appl Microbiol"},{"key":"11071_CR116","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1053\/j.gastro.2024.05.014","volume":"167","author":"R Wang","year":"2024","unstructured":"Wang R, Li B, Huang B et al (2024) Gut microbiota-derived butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis. Gastroenterology 167:733-749.e3. https:\/\/doi.org\/10.1053\/j.gastro.2024.05.014","journal-title":"Gastroenterology"},{"key":"11071_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1422770","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang J, Chen L, Zhao S-S et al (2024) FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate. Front Pharmacol 15:1422770. https:\/\/doi.org\/10.3389\/fphar.2024.1422770","journal-title":"Front Pharmacol"},{"key":"11071_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01655-2","volume":"11","author":"Y Wen","year":"2023","unstructured":"Wen Y, Yang L, Wang Z et al (2023) Blocked conversion of Lactobacillus johnsonii derived acetate to butyrate mediates copper-induced epithelial barrier damage in a pig model. Microbiome 11:218. https:\/\/doi.org\/10.1186\/s40168-023-01655-2","journal-title":"Microbiome"},{"key":"11071_CR119","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell DW (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72:137\u2013174. https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161712","journal-title":"Annu Rev Biochem"},{"key":"11071_CR120","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0016-5085(99)70042-9","volume":"116","author":"AF Hofmann","year":"1999","unstructured":"Hofmann AF (1999) Bile acids, cholesterol, gallstone calcification, and the enterohepatic circulation of bilirubin. Gastroenterology 116:1276\u20131277. https:\/\/doi.org\/10.1016\/S0016-5085(99)70042-9","journal-title":"Gastroenterology"},{"key":"11071_CR121","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","volume":"3","author":"KM Schneider","year":"2021","unstructured":"Schneider KM, Candels LS, Hov JR et al (2021) Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling. Nat Metab 3:1228\u20131241. https:\/\/doi.org\/10.1038\/s42255-021-00452-1","journal-title":"Nat Metab"},{"key":"11071_CR122","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.chembiol.2015.02.005","volume":"22","author":"LM Alkhalaf","year":"2015","unstructured":"Alkhalaf LM, Ryan KS (2015) Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms. Chemistry & Biology 22:317\u2013328. https:\/\/doi.org\/10.1016\/j.chembiol.2015.02.005","journal-title":"Chemistry & Biology"},{"key":"11071_CR123","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H (2018) Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23:716\u2013724. https:\/\/doi.org\/10.1016\/j.chom.2018.05.003","journal-title":"Cell Host Microbe"},{"key":"11071_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/nu11092062","volume":"11","author":"Y Ji","year":"2019","unstructured":"Ji Y, Gao Y, Chen H et al (2019) Indole-3-Acetic Acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress. Nutrients 11:2062. https:\/\/doi.org\/10.3390\/nu11092062","journal-title":"Nutrients"},{"key":"11071_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103509","volume":"13","author":"R Sehgal","year":"2021","unstructured":"Sehgal R, Ilha M, Vaittinen M et al (2021) Indole-3-propionic acid, a gut-derived tryptophan metabolite, associates with hepatic fibrosis. Nutrients 13:3509. https:\/\/doi.org\/10.3390\/nu13103509","journal-title":"Nutrients"},{"key":"11071_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0304-5","volume":"51","author":"Z-H Zhao","year":"2019","unstructured":"Zhao Z-H, Xin F-Z, Xue Y et al (2019) Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. Exp Mol Med 51:1\u201314. https:\/\/doi.org\/10.1038\/s12276-019-0304-5","journal-title":"Exp Mol Med"},{"key":"11071_CR127","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1096\/fj.12-223339","volume":"27","author":"R Valladares","year":"2013","unstructured":"Valladares R, Bojilova L, Potts AH et al (2013) Lactobacillus johnsonii inhibits indoleamine 2,3-dioxygenase and alters tryptophan metabolite levels in BioBreeding rats. The FASEB Journal 27:1711\u20131720. https:\/\/doi.org\/10.1096\/fj.12-223339","journal-title":"The FASEB Journal"},{"key":"11071_CR128","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/hep.31228","volume":"72","author":"A Isaacs-Ten","year":"2020","unstructured":"Isaacs-Ten A, Echeandia M, Moreno-Gonzalez M et al (2020) Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability in mice. Hepatology 72:2090\u20132108. https:\/\/doi.org\/10.1002\/hep.31228","journal-title":"Hepatology"},{"key":"11071_CR129","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","volume":"18","author":"R Wang","year":"2021","unstructured":"Wang R, Tang R, Li B et al (2021) Gut microbiome, liver immunology, and liver diseases. Cell Mol Immunol 18:4\u201317. https:\/\/doi.org\/10.1038\/s41423-020-00592-6","journal-title":"Cell Mol Immunol"},{"key":"11071_CR130","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2023-100007","volume":"1","author":"HCH Lau","year":"2023","unstructured":"Lau HCH, Zhang X, Yu J (2023) Gut microbiota and immune alteration in cancer development: implication for immunotherapy. eGastroenterology 1:e100007. https:\/\/doi.org\/10.1136\/egastro-2023-100007","journal-title":"eGastroenterology"},{"key":"11071_CR131","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","volume":"13","author":"F Heymann","year":"2016","unstructured":"Heymann F, Tacke F (2016) Immunology in the liver\u2013from homeostasis to disease. Nat Rev Gastroenterol Hepatol 13:88\u2013110. https:\/\/doi.org\/10.1038\/nrgastro.2015.200","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11071_CR132","doi-asserted-by":"publisher","DOI":"10.1289\/EHP10281","volume":"130","author":"L Jiang","year":"2022","unstructured":"Jiang L, Hong Y, Xiao P et al (2022) The role of fecal microbiota in liver toxicity induced by Perfluorooctane Sulfonate in male and female mice. Environ Health Perspect 130:67009. https:\/\/doi.org\/10.1289\/EHP10281","journal-title":"Environ Health Perspect"},{"key":"11071_CR133","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1080\/19490976.2020.1712984","volume":"11","author":"NY Lee","year":"2020","unstructured":"Lee NY, Yoon SJ, Han DH et al (2020) Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. Gut Microbes 11:882\u2013899. https:\/\/doi.org\/10.1080\/19490976.2020.1712984","journal-title":"Gut Microbes"},{"key":"11071_CR134","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1038\/s41467-025-58407-z","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang J, Yang J, Luo J et al (2025) Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma. Nat Commun 16:3315. https:\/\/doi.org\/10.1038\/s41467-025-58407-z","journal-title":"Nat Commun"},{"key":"11071_CR135","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2252447","volume":"15","author":"AE Cuaycal","year":"2023","unstructured":"Cuaycal AE, Teixeira LD, Lorca GL, Gonzalez CF (2023) Lactobacillus johnsonii N6.2 phospholipids induce immature-like dendritic cells with a migratory-regulatory-like transcriptional signature. Gut Microbes 15:2252447. https:\/\/doi.org\/10.1080\/19490976.2023.2252447","journal-title":"Gut Microbes"},{"key":"11071_CR136","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1128\/IAI.70.4.2057-2064.2002","volume":"70","author":"K Vidal","year":"2002","unstructured":"Vidal K, Donnet-Hughes A, Granato D (2002) Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect Immun 70:2057\u20132064. https:\/\/doi.org\/10.1128\/IAI.70.4.2057-2064.2002","journal-title":"Infect Immun"},{"key":"11071_CR137","doi-asserted-by":"publisher","unstructured":"Shida K, Kiyoshima-Shibata J, Kaji R et al (2009) Peptidoglycan from lactobacilli inhibits interleukin\u201012 production by macrophages induced by Lactobacillus casei through Toll\u2010like receptor 2\u2010dependent and independent mechanisms. Immunology 128. https:\/\/doi.org\/10.1111\/j.1365-2567.2009.03095.x","DOI":"10.1111\/j.1365-2567.2009.03095.x"},{"key":"11071_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62843-0","volume":"14","author":"RE Beliakoff","year":"2024","unstructured":"Beliakoff RE, Gonzalez CF, Lorca GL (2024) Bile promotes Lactobacillus johnsonii N6.2 extracellular vesicle production with conserved immunomodulatory properties. Sci Rep 14:12272. https:\/\/doi.org\/10.1038\/s41598-024-62843-0","journal-title":"Sci Rep"},{"key":"11071_CR139","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2560019","volume":"17","author":"Z Ma","year":"2025","unstructured":"Ma Z, Wang Z, Cao J et al (2025) Regulatory roles of intestinal CD4\u2009+\u2009T cells in inflammation and their modulation by the intestinal microbiota. Gut Microbes 17:2560019. https:\/\/doi.org\/10.1080\/19490976.2025.2560019","journal-title":"Gut Microbes"},{"key":"11071_CR140","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.3390\/nu17152537","volume":"17","author":"J Chen","year":"2025","unstructured":"Chen J, Zhang L, Jiao Y et al (2025) Lacticaseibacillus paracasei L21 and its postbiotics ameliorate ulcerative colitis through gut microbiota modulation, intestinal barrier restoration, and HIF1\u03b1\/AhR-IL-22 Axis Activation: Combined In Vitro and In Vivo Evidence. Nutrients 17:2537. https:\/\/doi.org\/10.3390\/nu17152537","journal-title":"Nutrients"},{"key":"11071_CR141","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.dld.2016.11.011","volume":"49","author":"M Toscano","year":"2017","unstructured":"Toscano M, De Grandi R, Miniello VL et al (2017) Ability of Lactobacillus kefiri LKF01 (DSM32079) to colonize the intestinal environment and modify the gut microbiota composition of healthy individuals. Dig Liver Disease 49:261\u2013267. https:\/\/doi.org\/10.1016\/j.dld.2016.11.011","journal-title":"Dig Liver Disease"},{"key":"11071_CR142","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/19490976.2018.1547612","volume":"10","author":"MJ Davoren","year":"2019","unstructured":"Davoren MJ, Liu J, Castellanos J et al (2019) A novel probiotic, Lactobacillus johnsonii 456, resists acid and can persist in the human gut beyond the initial ingestion period. Gut Microbes 10:458\u2013480. https:\/\/doi.org\/10.1080\/19490976.2018.1547612","journal-title":"Gut Microbes"},{"key":"11071_CR143","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1017\/S0007114507764723","volume":"98","author":"Y Fukushima","year":"2007","unstructured":"Fukushima Y, Miyaguchi S, Yamano T et al (2007) Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533). Br J Nutr 98:969\u2013977. https:\/\/doi.org\/10.1017\/S0007114507764723","journal-title":"Br J Nutr"},{"key":"11071_CR144","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/mbo3.252","volume":"4","author":"Y Aiba","year":"2015","unstructured":"Aiba Y, Nakano Y, Koga Y et al (2015) A highly acid-resistant novel strain of Lactobacillus johnsonii 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice. Microbiologyopen 4:465\u2013474. https:\/\/doi.org\/10.1002\/mbo3.252","journal-title":"Microbiologyopen"},{"key":"11071_CR145","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3389\/fimmu.2017.00655","volume":"8","author":"GE Marcial","year":"2017","unstructured":"Marcial GE, Ford AL, Haller MJ et al (2017) Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults. Front Immunol 8:655. https:\/\/doi.org\/10.3389\/fimmu.2017.00655","journal-title":"Front Immunol"},{"key":"11071_CR146","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1079\/BJN20051507","volume":"95","author":"T Yamano","year":"2006","unstructured":"Yamano T, Iino H, Takada M et al (2006) Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1. Br J Nutr 95:303\u2013312. https:\/\/doi.org\/10.1079\/BJN20051507","journal-title":"Br J Nutr"},{"key":"11071_CR147","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.femsle.2005.05.045","volume":"248","author":"D Garrido","year":"2005","unstructured":"Garrido D, Suau A, Pochart P et al (2005) Modulation of the fecal microbiota by the intake of a Lactobacillus johnsonii La1-containing product in human volunteers. FEMS Microbiol Lett 248:249\u2013256. https:\/\/doi.org\/10.1016\/j.femsle.2005.05.045","journal-title":"FEMS Microbiol Lett"},{"key":"11071_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/nu14214492","volume":"14","author":"N Danshiitsoodol","year":"2022","unstructured":"Danshiitsoodol N, Noda M, Kanno K et al (2022) Plant-derived Lactobacillus paracasei IJH-SONE68 improves the gut microbiota associated with hepatic disorders: a randomized, double-blind, and placebo-controlled clinical trial. Nutrients 14:4492. https:\/\/doi.org\/10.3390\/nu14214492","journal-title":"Nutrients"},{"key":"11071_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202100108","volume":"65","author":"K Xiong","year":"2021","unstructured":"Xiong K, Cai J, Liu P et al (2021) Lactobacillus casei alleviated the abnormal increase of cholestasis-related liver indices during tuberculosis treatment: a post hoc analysis of randomized controlled trial. Mol Nutr Food Res 65:2100108. https:\/\/doi.org\/10.1002\/mnfr.202100108","journal-title":"Mol Nutr Food Res"},{"key":"11071_CR150","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.14309\/ajg.0000000000002283","volume":"118","author":"V Vatsalya","year":"2023","unstructured":"Vatsalya V, Feng W, Kong M et al (2023) The beneficial effects of Lactobacillus GG therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis. Am J Gastroenterol 118:1457\u20131460. https:\/\/doi.org\/10.14309\/ajg.0000000000002283","journal-title":"Am J Gastroenterol"},{"key":"11071_CR151","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/apt.12695","volume":"39","author":"JS Bajaj","year":"2014","unstructured":"Bajaj JS, Heuman DM, Hylemon PB et al (2014) Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther 39:1113\u20131125. https:\/\/doi.org\/10.1111\/apt.12695","journal-title":"Aliment Pharmacol Ther"},{"key":"11071_CR152","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/nu12061651","volume":"12","author":"J Macnaughtan","year":"2020","unstructured":"Macnaughtan J, Figorilli F, Garc\u00eda-L\u00f3pez E et al (2020) A double-blind, randomized placebo-controlled trial of probiotic lactobacillus casei shirota in stable cirrhotic patients. Nutrients 12:1651. https:\/\/doi.org\/10.3390\/nu12061651","journal-title":"Nutrients"},{"key":"11071_CR153","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3748\/wjg.v30.i11.1556","volume":"30","author":"Y-C Hu","year":"2024","unstructured":"Hu Y-C, Ding X-C, Liu H-J et al (2024) Effects of Lactobacillus paracasei N1115 on gut microbial imbalance and liver function in patients with Hepatitis B-related cirrhosis. World J Gastroenterol 30:1556\u20131571. https:\/\/doi.org\/10.3748\/wjg.v30.i11.1556","journal-title":"World J Gastroenterol"},{"key":"11071_CR154","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","volume":"48","author":"V Stadlbauer","year":"2008","unstructured":"Stadlbauer V, Mookerjee RP, Hodges S et al (2008) Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol 48:945\u2013951. https:\/\/doi.org\/10.1016\/j.jhep.2008.02.015","journal-title":"J Hepatol"},{"key":"11071_CR155","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.3390\/nu13093192","volume":"13","author":"MH Mohamad Nor","year":"2021","unstructured":"Mohamad Nor MH, Ayob N, Mokhtar NM et al (2021) The effect of probiotics (MCP\u00ae BCMC\u00ae Strains) on hepatic steatosis, small intestinal mucosal immune function, and intestinal barrier in patients with non-alcoholic fatty liver disease. Nutrients 13:3192. https:\/\/doi.org\/10.3390\/nu13093192","journal-title":"Nutrients"},{"key":"11071_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020640","volume":"11","author":"N Ayob","year":"2023","unstructured":"Ayob N, Muhammad Nawawi KN, Mohamad Nor MH et al (2023) The effects of probiotics on small intestinal microbiota composition, inflammatory cytokines and intestinal permeability in patients with non-alcoholic fatty liver disease. Biomedicines 11:640. https:\/\/doi.org\/10.3390\/biomedicines11020640","journal-title":"Biomedicines"},{"key":"11071_CR157","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.3168\/jds.2014-8500","volume":"97","author":"S Nabavi","year":"2014","unstructured":"Nabavi S, Rafraf M, Somi MH et al (2014) Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J Dairy Sci 97:7386\u20137393. https:\/\/doi.org\/10.3168\/jds.2014-8500","journal-title":"J Dairy Sci"},{"key":"11071_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1362694","volume":"11","author":"AS Silva-Sperb","year":"2024","unstructured":"Silva-Sperb AS, Moraes HA, Barcelos STA et al (2024) Probiotic supplementation for 24 weeks in patients with non-alcoholic steatohepatitis: the PROBILIVER randomized clinical trial. Front Nutr 11:1362694. https:\/\/doi.org\/10.3389\/fnut.2024.1362694","journal-title":"Front Nutr"},{"key":"11071_CR159","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.tjnut.2023.05.019","volume":"153","author":"GS Escouto","year":"2023","unstructured":"Escouto GS, Port GZ, Tovo CV et al (2023) Probiotic supplementation, hepatic fibrosis, and the microbiota profile in patients with Nonalcoholic Steatohepatitis: a randomized controlled trial. J Nutr 153:1984\u20131993. https:\/\/doi.org\/10.1016\/j.tjnut.2023.05.019","journal-title":"J Nutr"},{"key":"11071_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100769","volume":"28","author":"STA Barcelos","year":"2023","unstructured":"Barcelos STA, Silva-Sperb AS, Moraes HA et al (2023) Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: a double-blind placebo-controlled randomized study. Ann Hepatol 28:100769. https:\/\/doi.org\/10.1016\/j.aohep.2022.100769","journal-title":"Ann Hepatol"},{"key":"11071_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/nu14163384","volume":"14","author":"I Burakova","year":"2022","unstructured":"Burakova I, Smirnova Y, Gryaznova M et al (2022) The effect of short-term consumption of lactic acid bacteria on the gut microbiota in obese people. Nutrients 14:3384. https:\/\/doi.org\/10.3390\/nu14163384","journal-title":"Nutrients"},{"key":"11071_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4750795","volume":"2019","author":"HPV Rupasinghe","year":"2019","unstructured":"Rupasinghe HPV, Parmar I, Neir SV (2019) Biotransformation of cranberry proanthocyanidins to probiotic metabolites by Lactobacillus rhamnosus enhances their anticancer activity in HepG2 cells in vitro. Oxid Med Cell Longev 2019:1\u201314. https:\/\/doi.org\/10.1155\/2019\/4750795","journal-title":"Oxid Med Cell Longev"},{"key":"11071_CR163","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","volume":"17","author":"KS Swanson","year":"2020","unstructured":"Swanson KS, Gibson GR, Hutkins R et al (2020) The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol 17:687\u2013701. https:\/\/doi.org\/10.1038\/s41575-020-0344-2","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11071_CR164","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen S, Collado MC, Endo A et al (2021) The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol 18:649\u2013667. https:\/\/doi.org\/10.1038\/s41575-021-00440-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11071_CR165","doi-asserted-by":"publisher","unstructured":"Arellano-Garc\u00eda LI, Milton-Laskibar I, Mart\u00ednez JA et al (2024) Comparative effects of viable Lactobacillus rhamnosus GG and its heat-inactivated paraprobiotic in the prevention of high-fat high-fructose diet-induced non-alcoholic fatty liver disease in rats.\u00a0Biofactors. https:\/\/doi.org\/10.1002\/biof.2116.\u00a0","DOI":"10.1002\/biof.2116"},{"key":"11071_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113522","volume":"23","author":"Z Pan","year":"2022","unstructured":"Pan Z, Mao B, Zhang Q et al (2022) Postbiotics prepared using Lactobacillus paracasei CCFM1224 prevent nonalcoholic fatty liver disease by modulating the gut microbiota and liver metabolism. Int J Mol Sci 23:13522. https:\/\/doi.org\/10.3390\/ijms232113522","journal-title":"Int J Mol Sci"},{"key":"11071_CR167","doi-asserted-by":"publisher","first-page":"11627","DOI":"10.1021\/acs.jafc.9b04323","volume":"67","author":"R Xu","year":"2019","unstructured":"Xu R, Aruhan n, Xiu L et al (2019) Exopolysaccharides from Lactobacillus buchneri TCP016 attenuate LPS- and d-GalN-induced liver injury by modulating the gut microbiota. J Agric Food Chem 67:11627\u201311637. https:\/\/doi.org\/10.1021\/acs.jafc.9b04323","journal-title":"J Agric Food Chem"},{"key":"11071_CR168","doi-asserted-by":"publisher","DOI":"10.3390\/nu15040845","volume":"15","author":"W Ye","year":"2023","unstructured":"Ye W, Chen Z, He Z et al (2023) Lactobacillus plantarum-derived postbiotics ameliorate acute alcohol-induced liver injury by protecting cells from oxidative damage, improving lipid metabolism, and regulating intestinal microbiota. Nutrients 15:845. https:\/\/doi.org\/10.3390\/nu15040845","journal-title":"Nutrients"},{"key":"11071_CR169","doi-asserted-by":"publisher","first-page":"e2300927","DOI":"10.1002\/mnfr.202300927","volume":"68","author":"C Liu","year":"2024","unstructured":"Liu C, Cai T, Cheng Y et al (2024) Postbiotics prepared using lactobacillus reuteri ameliorates ethanol-induced liver injury by regulating the FXR\/SHP\/SREBP-1c axis. Mol Nutr Food Res 68:e2300927. https:\/\/doi.org\/10.1002\/mnfr.202300927","journal-title":"Mol Nutr Food Res"},{"key":"11071_CR170","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/hep.20194","volume":"39","author":"Q Liu","year":"2004","unstructured":"Liu Q, Duan ZP, Ha DK et al (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39:1441\u20131449. https:\/\/doi.org\/10.1002\/hep.20194","journal-title":"Hepatology"},{"key":"11071_CR171","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2478\/rjim-2024-0004","volume":"62","author":"M Mitrovi\u0107","year":"2024","unstructured":"Mitrovi\u0107 M, Dobrosavljevi\u0107 A, Odanovi\u0107 O et al (2024) The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial. Rom J Intern Med 62:184\u2013193. https:\/\/doi.org\/10.2478\/rjim-2024-0004","journal-title":"Rom J Intern Med"},{"key":"11071_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/nu16091300","volume":"16","author":"A Mantri","year":"2024","unstructured":"Mantri A, K\u00f6hlmoos A, Schelski DS et al (2024) Impact of synbiotic intake on liver metabolism in metabolically healthy participants and its potential preventive effect on metabolic-dysfunction-associated fatty liver disease (MAFLD): a randomized, placebo-controlled, double-blinded clinical trial. Nutrients 16:1300. https:\/\/doi.org\/10.3390\/nu16091300","journal-title":"Nutrients"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11071-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11071-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11071-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:29:59Z","timestamp":1780126199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11071-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":172,"alternative-id":["11071"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11071-1","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}